Jerry Parrott joined BioMarker Strategies as CEO in October 2013. He also serves as Chairman, Maryland Health Care Product Development Corporation. Jerry served Human Genome Sciences (HGSI) as VP, Corporate Affairs and Public Policy, from 2001 until its 2012 acquisition by GlaxoSmithKline. He formerly held senior positions with Bristol-Myers Squibb, American Hospital Supply and Walgreen Company. From 1995-2001, Jerry’s consulting clients included HGSI, Bristol-Myers Squibb, Ciba-Geigy, Genentech, HealthCare Ventures, Hoffmann-La Roche, Rock Hill Ventures, Wyeth and others. He helped take public 3-Dimensional Pharmaceuticals, acquired by Johnson & Johnson, and InforMax, acquired by Invitrogen. Jerry is a Director of MdBio and Tech Council of Maryland. He formerly served as Senior Advisor to the Maryland Life Sciences Advisory Board, and as Chair of the Biotechnology Innovation Organization (BIO) Committee on Outreach and Alliance Development, Chair of the Rx Partners health care reform coalition, Founding Director of BioHealth Innovation, Founding Trustee of the Foundation for Genetic Medicine, and Trustee of the Committee for Economic Development.